Impact on total population health and societal cost, and the implication on the actual cost-effectiveness of including tumour necrosis factor-α antagonists in management of ankylosing spondylitis: A dynamic population modelling study

2015-10-07

Additional Metadata
Keywords	Ankylosing spondylitis, Budget impact, Cost-effectiveness, Cost-utility, Discrete event simulation, Health impact, Microsimulation, Modelling, Population dynamics, Tumor necrosis factor
Persistent URL	doi.org/10.1186/s12962-015-0044-x, hdl.handle.net/1765/83151
Journal	Cost Effectiveness and Resource Allocation
Organisation	Erasmus School of Health Policy & Management (ESHPM)
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Tran-Duy, A., Boonen, A., van de Laar, M., & Severens, H. (2015). Impact on total population health and societal cost, and the implication on the actual cost-effectiveness of including tumour necrosis factor-α antagonists in management of ankylosing spondylitis: A dynamic population modelling study. Cost Effectiveness and Resource Allocation, 13(1). doi:10.1186/s12962-015-0044-x

Publication